Late steroid withdrawal and cardiovascular events in kidney transplant recipients

Transplantation

Volumn 86, Issue 12, 2008, Pages 1844-1848

  Arnol, Miha ^a,b   De Mattos, Angelo M ^c   Chung, Jae S ^a   Prather, Jonathan C ^a   Mittalhenkle, Anuja ^a   Norman, Douglas J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular events; Kidney transplantation; Patient mortality; Steroid withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; CORTICOSTEROID;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HAZARD RATIO; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; DRUG ADMINISTRATION; HEART DISEASE; MIDDLE AGED; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RACE; SURVIVAL; TIME;

ADRENAL CORTEX HORMONES; ADULT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART DISEASES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 58849157360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818ffec0     Document Type: Article

References (25)

1. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001; 72(6 suppl): S5.
2. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735.
3. Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation. I.The impactofdialysis pre-transplant.Kidney Int1998; 53: 767.
4. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
5. De Mattos AM, Prather J, Olyaei AJ, et al. Cardiovascular events following renal transplantation: Role of traditional and transplantspecific risk factors. Kidney Int 2006; 70: 757.
6. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transpl 2002; 2: 807.
7. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-New mechanisms for old drugs. N Engl J Med 2005; 353: 1711.
8. Schacke H, Docke WD, Asdullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23.
9. Fryer JP, Granger DK, Leventhal JR, et al. Steroid-related complications in the cyclosporine era. Clin Transplant 1994; 8: 224.
10. Hollander AA, Hene RJ, Hermans J, et al. Late prednisone withdrawal in cyclosporine treated patients: Arandomized study. J Am Soc Nephrol 1997; 8: 294.
11. Vanrenterghem Y, Lebranchu Y, Hene R, et al. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352.
12. Smak Gregoor PJ, de Sévaux RG, Ligtenberg G, et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicenter study. J Am Soc Nephrol 2002; 13: 1365.
13. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001; 37: 1162.
14. Midtvedt K, Hjelmesaeth J, Hartmann A, et al. Insulin resistance after renal transplantation: The effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004; 15: 3233.
15. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959.
16. Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation. Drug Saf 1995; 13: 145.
17. Sinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. CMAJ 1992; 147: 645.
18. Opelz G, Döhler B, Laux G; for the Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005; 5: 720.
19. Parfrey PS, Foley RN, Harnett JD. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277.
20. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
21. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071.
22. Holdaas H, Fellström B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomized, placebo-controlled trial. Lancet 2003; 361: 2024.
23. Hjelmesaeth J, Midtvedt K, Jenssen T, et al. Insulin resistance after renal transplantation: Impact of immunosuppressive and antihypertensive therapy. Diabetes care 2001; 24: 2121.
24. Kasiske BL, Snyder JJ, GilbertsonD, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
25. Fabrega AJ, Meslar P, Cohan J, et al. Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus. Transplantation 1995; 60: 1612.